Argo Biotech ApS: Financial statements 2020
CVR: 41133937
Source: annual report 2020, Danish Business Authority
30/01/2020 – 31/12/2020
Argo Biotech ApS (CVR 41133937) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -27,201 and a net result of DKK -27,365. Equity in the 2020 report amounted to DKK 12,635. The solvency ratio was 35.5%.
- Revenue
- DKK 0
- Gross Profit
- DKK -27,201
- Profit/Loss
- DKK -27,365
- Equity
- DKK 12,635
- Total Assets
- DKK 35,616
Official annual report
How creditworthy is Argo Biotech ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of January 30, 2020, Casper Tind Hansen is registered as adm. dir. of Argo Biotech ApS.
Argo Biotech ApS was founded on January 30, 2020.
About Argo Biotech ApS
Argo Biotech ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2020. The company has been dissolved on 16 August 2023. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2022, the company reported a gross profit of DKK 0 and a net result of DKK -80 compared with DKK -96 the year before. Equity in the 2022 report amounted to DKK 12,258.
